Posts

Study identifies biomarker that could predict whether c...

MIAMI, FLORIDA (July 25, 2024) – Many people with stage II or III colon cancer r...

Brazil Curbs Poultry Exports Amid Newcastle Viral Disease

Brazil has restricted its exports of chicken meat and eggs to 44 nations after t...

Ionis Plans to Advance Angelman drug Biogen with clinic...

Ionis Pharmaceuticals is set to advance one of its drugs for Angelman syndrome t...

AstraZeneca Grows EGFR Portfolio with $45M Pinetree Deal

Pinetree Therapeutics, a biotechnology firm focused on developing targeted prote...

RSV Antibody Passes Final Trials in Win for Merck

Merck & Co. hope to become the latest company to gain approval for a drug to ave...

MHRA approves Pfizer-BioNTech’s Comirnaty JN.1 vaccine

The UK MHRA has authorised Pfizer-BioNTech’s adapted Comirnaty vaccine against t...

BioAtla receives FDA fast track designation for ozurift...

The Phase II antibody drug conjugate received FDA fast track designation against...

The potential of 3D printing in drug development and de...

3D printing is replacing traditional prototype development approaches across var...

AC Immune wins FDA fast track for Alzheimer’s vaccine c...

JNJ-2056 is being investigated in the Phase IIb ReTain study which enrols partic...

Ipsen outlines $461m for ex-US rights to Day One’s glio...

Ipsen will pay $111m in cash and equity upfront to gain the global rights, exclu...

Sandoz launches ustekinumab biosimilar in Europe 

Sandoz launched the biosimilar of J&J’s Stelara in Europe in partnership with Sa...

ConSynance wins FDA designation for Prader-Willi syndro...

A Phase II study for ConSynance’s triple monoamine reuptake inhibitor CSTI-500 i...

FDA agrees wider use of BioMarin’s BRINEURA for CLN2

The US FDA has expanded approval to BioMarin Pharmaceutical's BRINEURA to includ...

NICE recommends Boehringer’s tenecteplase for NHS strok...

The UK NICE has issued final guidance endorsing Boehringer Ingelheim’s tenectepl...

Dren Bio and Novartis link on bispecific antibodies for...

Dren Bio has entered a strategic partnership with Novartis Pharma to develop the...

Tackling industrial emissions begins at the chemical re...

University of Sydney researchers are proposing a new way to curb industrial emis...